SCHEDULE: Linden Entities Disclose Spartacus Acquisition Corp. II Stake
Schedule 13G Filing
Linden Capital L.P. and affiliated entities have filed a Schedule 13G, reporting beneficial ownership of 5.3% to 5.5% of Spartacus Acquisition Corp. II's Class A Ordinary Shares as of August 3, 2026.
Summary
- This filing is a Schedule 13G, a report of beneficial ownership of securities.
- The reporting persons are Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong.
- They collectively report beneficial ownership of Spartacus Acquisition Corp. II's Class A Ordinary Shares.
- As of August 3, 2026, Linden Advisors and Mr. Wong beneficially own 1,253,854 shares, representing approximately 5.5% of the class.
- This ownership includes 1,211,717 shares held by Linden Capital and 42,137 shares held by Managed Accounts.
- Linden GP and Linden Capital beneficially own 1,211,717 shares, representing approximately 5.3% of the class.
- The filing confirms that these securities were not acquired for the purpose of influencing control of the issuer.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a neutral filing, primarily a procedural disclosure of beneficial ownership rather than a report on operational performance or strategic shifts.
Positives
- Clear disclosure of beneficial ownership, providing transparency to the market.
- The reporting persons confirm that the shares were not acquired to influence control of the issuer, indicating a passive investment stance.
Negatives
- The filing does not contain financial performance data or operational updates, limiting insights into the company's health.
- The ownership percentages are relatively small (5.3%-5.5%), suggesting a non-controlling stake.
Risks
- As a Schedule 13G filing, it primarily concerns ownership and does not detail specific business risks or operational challenges of Spartacus Acquisition Corp. II.
- The nature of the reporting entities (investment partnerships and advisors) suggests potential for future changes in holdings, though not explicitly stated as a risk.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance.
Management Comments
- The reporting persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant shareholders in special purpose acquisition companies (SPACs) like Spartacus Acquisition Corp. II, indicating passive investment stakes.
Stakeholder Impact
- Shareholders gain transparency into significant beneficial ownership of Spartacus Acquisition Corp. II.
- The disclosure confirms a passive investment approach by Linden entities, which may be viewed positively by other investors seeking stability.
Next Steps
- Continued monitoring of Spartacus Acquisition Corp. II's activities and any subsequent filings by reporting persons.
Key Dates
| Date | Description |
|---|---|
| June 10, 2019 | Date of Power of Attorney for Siu Min Wong. |
| June 19, 2019 | Date of previous Schedule 13G filing by Linden Capital L.P. regarding Haymaker Acquisition Corp II. |
| August 3, 2026 | Date of event requiring filing of this statement and date as of which ownership is reported. |
| August 4, 2026 | Date of joint filing agreement and signature date. |
Keywords
Schedule 13G, Beneficial Ownership, Spartacus Acquisition Corp. II, Linden Capital, Linden Advisors, Class A Ordinary Shares, Acquisition Corp
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.